Sorrento Therapeutics Inc Net Income per Employee (SRNEQ), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Sorrento Therapeutics Inc   (SRNEQ)
 

Sorrento Therapeutics Inc Net Income per Employee

SRNEQ's Quarterly Results, Trends, Rankings, Statistics
Sorrento Therapeutics Inc recorded a cumulative net loss of $-354 million during 12 month ending in the second quarter 2023.
The Healthcare sector has seen Sorrento Therapeutics Inc achieved the highest income per employee. While income per employee remained unchanged compared to the previous quarter at no. .


What is Income per Employee Ratio?






SRNEQ Net Income per Employee (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -11,792,900 -15,490,933 -11,688,067 -16,516,800 -17,495,800
SRNEQ's Total Ranking # # # 2 # 4843 # 4899
Seq. Net Income Change - - - - -


SRNEQ Net Income per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Net Income per Employee Statistics
High Average Low
$ 826,878 $ -5,180,537 $ -17,495,800
(Dec 31 2013)   (Jun 30 2022)







Companies with similar Income per Employee for 12 month ending Jun 30 2023, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2023Number of Employees Jun 30 2023


Date modified: 2026-08-29T17:19:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.